sv se
  • New mechanism of action
  • Bacterial vaginosis
  • Non antibiotic
Bacterial vaginosis is very common, especially in women of childbearing age. Within the EU, between 15 and 45 million women are affected by bacterial vaginosis every year. The symptoms of bacterial vaginosis can be painful; it hurts, burns and can also smell bad. The infection is caused by an imbalance of the vaginal and is treated with antibiotics. Gedea aims to develop the first antibiotic-free treatment that both prevents and treats bacterial vaginosis.
NEWS: Result from clinical trial
Gedea releases results from clinical trial.
Read more >>
kartaGedea Biotech AB
Medicon Village
Scheelevägen 2
223 81 Lund
Sweden
Annette Säfholm, CEO
annette.safholm@gedeabiotech.com
+46 (0) 708 - 91 86 81
nyhetsbrev
Eit